ARCHIVES

Perifosine Fails Primary Endpoint, Zentaris CEO Explores Options

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: In Vitro Systems Will Be 90% Reliable, Ames Says; GAO Asks For Reassessment of Saccharin

October 1, 1976

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

November 29, 1991

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

FDA Spells Out Requirement For INDs For Cancer Drugs.

May 17, 2002

DRCCA Board Cool On communications Network, Hears Report On Behavior Program

May 21, 1982

New Treatment Approach To Treating Brain Tumor

April 26, 2002